Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.69 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | DHODH | Q02127 | 1/20 | 0.49 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.49 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.49 |
| ▸ | SLC9A3 | P48764 | 1/20 | 0.49 |
| ▸ | SLC9A2 | Q9UBY0 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | FBP1 | P09467 | 2/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL476911 | 1.00 | AKR1C3 (0.69) | AKR1C3MCL1ALDH1A1TSHRHTT | |
| Phenol SCHEMBL29181787 | 0.92 | AKR1C3 (0.60) | AKR1C3MCL1ALDH1A1TSHRHTT | |
| SCHEMBL5830527 | 0.89 | AKR1C3 (0.52) | AKR1C3MCL1ALDH1A1HTTNPC1 | |
| SCHEMBL5830531 | 0.89 | AKR1C3 (0.52) | AKR1C3MCL1ALDH1A1HTTNPC1 | |
| SCHEMBL378903 | 0.84 | MAPT (0.51) | AKR1C3ALDH1A1TSHRHTTNPC1 | |
| SCHEMBL4622685 | 0.84 | MAPT (0.51) | AKR1C3ALDH1A1TSHRHTTNPC1 | |
| SCHEMBL29158024 | 0.84 | TBXAS1 (0.56) | AKR1C3MCL1ALDH1A1NPC1RAB9A | |
| SCHEMBL805622 | 0.82 | AKR1C3 (0.75) | AKR1C3ALDH1A1TSHRHTTNPC1 | |
| SCHEMBL759655 | 0.82 | AKR1C3 (0.75) | AKR1C3ALDH1A1TSHRHTTNPC1 | |
| SCHEMBL759656 | 0.82 | AKR1C3 (0.75) | AKR1C3ALDH1A1TSHRHTTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 339 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260040695-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | NEWSOUTH INNOVATIONS PTY LTD (AU) | 2026-02-05 | — | — | US | claimed |
| EP-4562077-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | NewSouth Innovations Pty Limited (AU) | 2025-06-04 | — | — | EP | claimed |
| US-12135503-B2 | Organometallic photoresists for DUV or EUV lithography | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2024-11-05 | — | — | US | claimed |
| WO-2024020649-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | NEWSOUTH INNOVATIONS PTY LIMITED (AU) | 2024-02-01 | — | — | WO | claimed |
| WO-2022261721-A1 | HEALABLE AND REPROCESSABLE COMPOSITIONS | DEAKIN UNIVERSITY (AU) | 2022-12-22 | — | — | WO | claimed |
| US-20220317572-A1 | ORGANOMETALLIC PHOTORESISTS FOR DUV OR EUV LITHOGRAPHY | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2022-10-06 | — | — | US | claimed |
| EP-3735439-A1 | STABLE ORGANIC LIGHT EMITTING COATING | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd (IL) | 2020-11-11 | — | — | EP | claimed |
| WO-2019135223-A1 | STABLE ORGANIC LIGHT EMITTING COATING | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) | 2019-07-11 | — | — | WO | claimed |
| EP-3298053-A1 | ENERGY CURABLE HYPERBRANCHED POLYCARBONATE POLYOL BACKBONE POLYFUNCTIONAL ACRYLATES | BASF Corporation (US) | 2018-03-28 | — | — | EP | claimed |
| EP-3191582-A1 | CELL CULTURE SUBSTRATE | The University Of Nottingham (GB) | 2017-07-19 | — | — | EP | claimed |
| EP-1562542-B1 | PERFUME POLYMERIC PARTICLES | PROCTER & GAMBLE (US) | 2009-10-14 | — | — | EP | claimed |
| EP-1660507-B1 | PROTEASOME INHIBITORS AND METHODS OF USING THE SAME | CEPHALON INC (US) | 2009-08-05 | — | — | EP | claimed |
| US-7504446-B2 | Aqueous inks containing colored polymers | XEROX CORPORATION (US) | 2009-03-17 | — | — | US | claimed |
| CN-1867572-A | proteasome inhibitors and methods of use thereof | CEPHALON INC (US) | 2006-11-22 | — | — | CN | claimed |
| EP-1660507-A2 | PROTEASOME INHIBITORS AND METHODS OF USING THE SAME | CEPHALON, INC. (US) | 2006-05-31 | — | — | EP | claimed |
| US-20060074142-A1 | Aqueous inks containing colored polymers | XEROX CORPORATION | 2006-04-06 | — | — | US | claimed |
| US-20050107307-A1 | Proteasome inhibitors and methods of using the same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-05-19 | — | — | US | claimed |
| WO-2005021558-A2 | PROTEASOME INHIBITORS AND METHODS OF USING THE SAME | CEPHALON, INC. (US) | 2005-03-10 | — | — | WO | claimed |
| US-5549807-A | Thermoplastic composites formed by electropolymerization of N-substituted methacrylamide monomers | THE UNIVERSITY OF CONNECTICUT (US) | 1996-08-27 | — | — | US | claimed |
| US-5238542-A | Onto electrically conductive filler | THE UNIVERSITY OF CONNECTICUT (US) | 1993-08-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050107307-A1 | Proteasome inhibitors and methods of using the same | PSMB11, PSMB5, PSMB6 | AKR1C3 2698/4885MCL1 60/4885ALDH1A1 3935/4885 |
| US-20260040695-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | PIEZO1, LCP1, MTCL3 | AKR1C3 4848/4885MCL1 2852/4885ALDH1A1 4717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.